tradingkey.logo
tradingkey.logo
Search

Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation For (Z)-Endoxifen For Mccune-Albright Syndrome

ReutersMay 4, 2026 12:34 PM
facebooktwitterlinkedin
View all comments0

- Atossa Therapeutics Inc ATOS.O:

  • ATOSSA THERAPEUTICS RECEIVES FDA RARE PEDIATRIC DISEASE DESIGNATION FOR (Z)-ENDOXIFEN FOR MCCUNE-ALBRIGHT SYNDROME

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI